azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen
['leukemia', 'myeloid']
now at #ash22: our dr. naval daver shares findings suggesting a novel triplet target therapy demonstrates manageable safety and anti-leukemia activity in certain patients with acute myeloid leukemia: #leukemia #endcancer 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789